* Prophase Labs Inc PRPH.OQ reported a quarterly adjusted
loss
of 12 cents per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was
for earnings of 3 cents per share.
* Revenue fell 51.7% to $21.83 million from a year ago;
analysts
expected $20.51 million.
* Prophase Labs Inc's reported EPS for the quarter was a
loss
of 12 cents.
* The mean earnings estimate of analysts had risen by
about 25% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Prophase Labs Inc shares had fallen by 15.3% this quarter.
* The company reported a quarterly loss of $2.45 million.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $15.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 28 at 01:31 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 0.03 -0.12 Missed
Sep. 30 2022 0.19 0.06 Missed
Jun. 30 2022 0.18 0.40 Beat
Mar. 31 2022 0.39 0.68 Beat